Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nobuhiko Ohki

Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly

Endocrine Journal

English

Long-Term Safety and Efficacy of Daily Recombinant Human Growth Hormone Treatment in Japanese Short Children Born Small for Gestational Age: Final Report From an Open and Multi-Center Study

Clinical Pediatric Endocrinology

English

Related publications

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy

Clinical Cancer Research

Cancer Research

Oncology

2007

English

Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant

Journal of Clinical Endocrinology and Metabolism

Biochemistry

Endocrinology

Clinical Biochemistry

English

Efficacy and Safety of Growth Hormone Replacement Therapy in Japanese Adults With Growth Hormone Deficiency: A Post-Marketing Observational Study

English

Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.

European Journal of Endocrinology

English

Clinical Efficacy of Tolterodine for Patients With Overactive Bladder After Insufficient Efficacy by Monotherapy With .Alpha.1-Adrenoceptor Antagonist

Japanese Journal of Urology

Urology

2009

English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

English

What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?

European Journal of Endocrinology

English

Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy

British Journal of Haematology

Hematology

2017

English

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening

Endocrine Abstracts

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Nobuhiko Ohki

Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly

Long-Term Safety and Efficacy of Daily Recombinant Human Growth Hormone Treatment in Japanese Short Children Born Small for Gestational Age: Final Report From an Open and Multi-Center Study

Related publications

Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy

Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant

Efficacy and Safety of Growth Hormone Replacement Therapy in Japanese Adults With Growth Hormone Deficiency: A Post-Marketing Observational Study

Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.

Clinical Efficacy of Tolterodine for Patients With Overactive Bladder After Insufficient Efficacy by Monotherapy With .Alpha.1-Adrenoceptor Antagonist

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

What Is the Efficacy of Switching to Weekly Pegvisomant in Acromegaly Patients Well Controlled on Combination Therapy?

Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy

Combined Treatment With Octreotide LAR and Pegvisomant in Patients With Gigantism - Acromegaly: Clinical Evaluation and Genetic Screening